Angiotensin II Receptors and Functional Correlates

Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hypertension 1992-12, Vol.5 (12-Pt-2), p.221S-235S
Hauptverfasser: Timmermans, Pieter B.M.W.M., Benfield, Pamela, Chiu, Andrew T., Herblin, William F., Wong, Pancras C., Smith, Ronald D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 235S
container_issue 12-Pt-2
container_start_page 221S
container_title American journal of hypertension
container_volume 5
creator Timmermans, Pieter B.M.W.M.
Benfield, Pamela
Chiu, Andrew T.
Herblin, William F.
Wong, Pancras C.
Smith, Ronald D.
description Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S
doi_str_mv 10.1093/ajh/5.12.221S
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73412210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73412210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</originalsourceid><addsrcrecordid>eNpNkEFPAjEQRhujQUSPHk32YLwtdNptuz0iimAwRtRovDSl29XFpYvtkui_dwkEncsk873MZB5Cp4C7gCXt6flHj3WBdAmBxz3UBplALAhh-6iNU8ligTkcoqMQ5hjjhHNooRYQ2UxFG5G-ey-q2rpQuGg8jqbW2GVd-RBpl0XDlTN1UTldRoPKe1vq2oZjdJDrMtiTbe-g5-H102AUT-5vxoP-JDaUsTrOTYqzmdGSCZLSPKEZZJRzk4EklBgphcxzaIrMUmm4ERm1JIOU0yQFTIF20MVm79JXXysbarUogrFlqZ2tVkEJmkDzM27AeAMaX4Xgba6Wvlho_6MAq7Uj1ThSTAFRa0cNf7ZdvJotbPZHb6Q0-fk218HoMvfamSLssIRRmtB_Z4tQ2-9drP2n4oIKpkavb-pqevcyusS36oH-AlOGfEU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73412210</pqid></control><display><type>article</type><title>Angiotensin II Receptors and Functional Correlates</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</creator><creatorcontrib>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</creatorcontrib><description>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1093/ajh/5.12.221S</identifier><identifier>PMID: 1290617</identifier><language>eng</language><publisher>New York, NY: Oxford University Press</publisher><subject>Acrylates - therapeutic use ; Angiotensin II ; angiotensin II receptor ; Angiotensin Receptor Antagonists ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Biphenyl Compounds - therapeutic use ; Blood Pressure - physiology ; Cardiovascular system ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Imidazoles - therapeutic use ; Losartan ; losartan (DuP 753) ; Medical sciences ; Pharmacology. Drug treatments ; Pyridines - therapeutic use ; Receptors, Angiotensin - physiology ; renin-angiotensin system ; Renin-Angiotensin System - drug effects ; Renin-Angiotensin System - physiology ; Tetrazoles - therapeutic use ; Thiophenes</subject><ispartof>American journal of hypertension, 1992-12, Vol.5 (12-Pt-2), p.221S-235S</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4533430$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1290617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Timmermans, Pieter B.M.W.M.</creatorcontrib><creatorcontrib>Benfield, Pamela</creatorcontrib><creatorcontrib>Chiu, Andrew T.</creatorcontrib><creatorcontrib>Herblin, William F.</creatorcontrib><creatorcontrib>Wong, Pancras C.</creatorcontrib><creatorcontrib>Smith, Ronald D.</creatorcontrib><title>Angiotensin II Receptors and Functional Correlates</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</description><subject>Acrylates - therapeutic use</subject><subject>Angiotensin II</subject><subject>angiotensin II receptor</subject><subject>Angiotensin Receptor Antagonists</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biphenyl Compounds - therapeutic use</subject><subject>Blood Pressure - physiology</subject><subject>Cardiovascular system</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Imidazoles - therapeutic use</subject><subject>Losartan</subject><subject>losartan (DuP 753)</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridines - therapeutic use</subject><subject>Receptors, Angiotensin - physiology</subject><subject>renin-angiotensin system</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Tetrazoles - therapeutic use</subject><subject>Thiophenes</subject><issn>0895-7061</issn><issn>1941-7225</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEFPAjEQRhujQUSPHk32YLwtdNptuz0iimAwRtRovDSl29XFpYvtkui_dwkEncsk873MZB5Cp4C7gCXt6flHj3WBdAmBxz3UBplALAhh-6iNU8ligTkcoqMQ5hjjhHNooRYQ2UxFG5G-ey-q2rpQuGg8jqbW2GVd-RBpl0XDlTN1UTldRoPKe1vq2oZjdJDrMtiTbe-g5-H102AUT-5vxoP-JDaUsTrOTYqzmdGSCZLSPKEZZJRzk4EklBgphcxzaIrMUmm4ERm1JIOU0yQFTIF20MVm79JXXysbarUogrFlqZ2tVkEJmkDzM27AeAMaX4Xgba6Wvlho_6MAq7Uj1ThSTAFRa0cNf7ZdvJotbPZHb6Q0-fk218HoMvfamSLssIRRmtB_Z4tQ2-9drP2n4oIKpkavb-pqevcyusS36oH-AlOGfEU</recordid><startdate>19921201</startdate><enddate>19921201</enddate><creator>Timmermans, Pieter B.M.W.M.</creator><creator>Benfield, Pamela</creator><creator>Chiu, Andrew T.</creator><creator>Herblin, William F.</creator><creator>Wong, Pancras C.</creator><creator>Smith, Ronald D.</creator><general>Oxford University Press</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921201</creationdate><title>Angiotensin II Receptors and Functional Correlates</title><author>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acrylates - therapeutic use</topic><topic>Angiotensin II</topic><topic>angiotensin II receptor</topic><topic>Angiotensin Receptor Antagonists</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biphenyl Compounds - therapeutic use</topic><topic>Blood Pressure - physiology</topic><topic>Cardiovascular system</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Imidazoles - therapeutic use</topic><topic>Losartan</topic><topic>losartan (DuP 753)</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridines - therapeutic use</topic><topic>Receptors, Angiotensin - physiology</topic><topic>renin-angiotensin system</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Tetrazoles - therapeutic use</topic><topic>Thiophenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Timmermans, Pieter B.M.W.M.</creatorcontrib><creatorcontrib>Benfield, Pamela</creatorcontrib><creatorcontrib>Chiu, Andrew T.</creatorcontrib><creatorcontrib>Herblin, William F.</creatorcontrib><creatorcontrib>Wong, Pancras C.</creatorcontrib><creatorcontrib>Smith, Ronald D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Timmermans, Pieter B.M.W.M.</au><au>Benfield, Pamela</au><au>Chiu, Andrew T.</au><au>Herblin, William F.</au><au>Wong, Pancras C.</au><au>Smith, Ronald D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II Receptors and Functional Correlates</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>1992-12-01</date><risdate>1992</risdate><volume>5</volume><issue>12-Pt-2</issue><spage>221S</spage><epage>235S</epage><pages>221S-235S</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><eissn>1879-1905</eissn><abstract>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</abstract><cop>New York, NY</cop><pub>Oxford University Press</pub><pmid>1290617</pmid><doi>10.1093/ajh/5.12.221S</doi></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 1992-12, Vol.5 (12-Pt-2), p.221S-235S
issn 0895-7061
1941-7225
1879-1905
language eng
recordid cdi_proquest_miscellaneous_73412210
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Acrylates - therapeutic use
Angiotensin II
angiotensin II receptor
Angiotensin Receptor Antagonists
Antihypertensive agents
Antihypertensive Agents - therapeutic use
Biological and medical sciences
Biphenyl Compounds - therapeutic use
Blood Pressure - physiology
Cardiovascular system
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Imidazoles - therapeutic use
Losartan
losartan (DuP 753)
Medical sciences
Pharmacology. Drug treatments
Pyridines - therapeutic use
Receptors, Angiotensin - physiology
renin-angiotensin system
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
Tetrazoles - therapeutic use
Thiophenes
title Angiotensin II Receptors and Functional Correlates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20Receptors%20and%20Functional%20Correlates&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Timmermans,%20Pieter%20B.M.W.M.&rft.date=1992-12-01&rft.volume=5&rft.issue=12-Pt-2&rft.spage=221S&rft.epage=235S&rft.pages=221S-235S&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/5.12.221S&rft_dat=%3Cproquest_cross%3E73412210%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73412210&rft_id=info:pmid/1290617&rfr_iscdi=true